Journal for ImmunoTherapy of Cancer

Journal

Overview
Identity

Publication Venue For

Impact of body composition on outcomes from anti-PD1 +/-anti-CTLA-4 treatment in melanoma. 8. 2020

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study. 8. 2020

Corrections to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma (Journal for ImmunoTherapy of Cancer (2019) 7 (139) DOI: 10.1186/s40425-019-0621-1). 7. 2019

Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma. 7. 2019

Smoldering myocarditis following immune checkpoint blockade. 5. 2017

Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction. 4. 2016

Electronic International Standard Serial Number (eissn)

2051-1426